Cefoperazone/sulbactam
Cefoperazone/sulbactam is a combination antibiotic used in the treatment of various bacterial infections. It is a combination of two active ingredients: cefoperazone, a third-generation cephalosporin, and sulbactam, a beta-lactamase inhibitor. This combination is particularly effective because sulbactam enhances the effectiveness of cefoperazone by inhibiting the enzymes that would otherwise degrade it.
Mechanism of Action[edit]
Cefoperazone works by inhibiting the synthesis of the bacterial cell wall, leading to cell death. Sulbactam, on the other hand, inhibits beta-lactamase, an enzyme produced by certain bacteria that can degrade and inactivate cefoperazone. By inhibiting this enzyme, sulbactam allows cefoperazone to remain active and exert its antibacterial effects.
Uses[edit]
Cefoperazone/sulbactam is used to treat a variety of bacterial infections, including those caused by Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. It is also used in the treatment of intra-abdominal infections, skin and soft tissue infections, and respiratory tract infections.
Side Effects[edit]
Common side effects of cefoperazone/sulbactam include nausea, vomiting, diarrhea, and rash. In rare cases, it can cause more serious side effects such as anaphylaxis, a severe allergic reaction.
Precautions[edit]
Patients with a history of allergy to cephalosporins or other beta-lactam antibiotics should not use cefoperazone/sulbactam. It should also be used with caution in patients with kidney disease or liver disease, as these conditions can affect the body's ability to metabolize and eliminate the drug.
Interactions[edit]
Cefoperazone/sulbactam can interact with other medications, including probenecid, which can increase the levels of cefoperazone in the body, and alcohol, which can lead to a disulfiram-like reaction when combined with cefoperazone.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian